Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 14981187.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors conducted an open study of levetiracetam as add-on therapy in nine patients with well-defined progressive myoclonic epilepsies and refractory myoclonus. Myoclonus was evaluated semiquantitatively (territory, intensity, daily living activities). Five patients had improvement of their myoclonus score. Levetiracetam may benefit myoclonus in progressive myoclonic epilepsy.
Medical subject headings
- Anticonvulsants
- MERRF Syndrome
- Piracetam
- Unverricht-Lundborg Syndrome